Clinical Trials Browser

INDUSTRY × Glioblastoma × IMA950 × Clear all

NCT01403285 2014-05-19

Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma

Phase 1 Terminated

Glioblastoma